Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis

American Journal of Cardiology

Volumn 109, Issue 11, 2012, Pages 1619-1625

  Mantziari, Lilian ^a,b   Guha, Kaushik ^a,c   Khalique, Zohya ^a   McDonagh, Theresa ^d   Sharma, Rakesh ^a,c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; PERINDOPRIL; RAMIPRIL; VALSARTAN;

AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; DOSE RESPONSE; DRUG TOLERABILITY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORTHOSTATIC HYPOTENSION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC RESYNCHRONIZATION THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LONDON; MALE; OUTPATIENT CLINICS, HOSPITAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84861191136     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.387     Document Type: Article

References (19)

1. J.L. Reid, R.J. MacFadyen, I.B. Squire, K.R. Lees Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Am J Cardiol 71 suppl 1993 57E 60E
2. M.H. Sami Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure Can J Cardiol 10 suppl D 1994 13D 16D
3. D. Simpson, S. Noble, K.L. Goa Perindopril: in congestive heart failure Drugs 62 2002 1367 1377
4. K. Dickstein, P.E. Vardas, A. Auricchio, J.C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S.G. Priori, R. Sutton, D.J. van Veldhuisen, A. Vahanian, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, S.D. Anker, J.J. Blanc, M. Gasparini, A.W. Hoes, C.W. Israel, Z. Kalarus, B. Merkely, K. Swedberg, A.J. Camm 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Europace 12 2010 1526 1536
5. J.T. Heywood, G.C. Fonarow, C.W. Yancy, N.M. Albert, A.B. Curtis, M. Gheorghiade, P.J. Inge, M.L. McBride, M.R. Mehra, C.M. O'Connor, D. Reynolds, M.N. Walsh Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF Circ Heart Fail 3 2010 596 605
6. P. Steendijk, S.A. Tulner, J.J. Bax, P.V. Oemrawsingh, G.B. Bleeker, L. van Erven, H. Putter, H.F. Verwey, E.E. van der Wall, M.J. Schalij Hemodynamic effects of Long-term cardiac resynchronization therapy: analysis by pressure-volume loops Circulation 113 2006 1295 1304
7. The Consensus Trial Study Group Effects of enalapril on mortality in severe congestive heart failure N Engl J Med 316 1987 1429 1435
8. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
9. M. Packer, P.A. Poole-Wilson, P.W. Armstrong, J.G. Cleland, J.D. Horowitz, B.M. Massie, L. Rydén, K. Thygesen, B.F. Uretsky Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure ATLAS study group Circulation 100 1999 2312 2318
10. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
11. A.P. Marc, S. Karl, B.G. Christopher, H. Peter, J.V.M. John, L.M. Eric, O. Bertil, Ö. Jan, Y. Salim, S. Pocock CHARM Investigators and Committees Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766
12. B. Pitt, P.A. Poole-Wilson, R. Segal, F.A. Martinez, K. Dickstein, A.J. Camm, M.A. Konstam, G. Riegger, G.H. Klinger, J. Neaton, D. Sharma, B. Thiyagarajan Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II Lancet 355 2000 1582 1587
13. M.A. Konstam, J.D. Neaton, K. Dickstein, H. Drexler, M. Komadja, F.A. Martinez, G.A. Riegger, W. Malbecq, R.D. Smith, S. Gupta, P.A. Poole-Wilson HEAAL Investigators Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial Lancet 374 2009 1840 1848
14. R. Bai, L. Di Biase, C. Elayi, C.K. Ching, C. Barrett, K. Philipps, P. Lim, D. Patel, T. Callahan, D.O. Martin, M. Arruda, R.A. Schweikert, W.I. Saliba, B. Wilkoff, A. Natale Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors J Cardiovasc Electrophysiol 19 2008 1259 1265
15. A. de Sisti, J.F. Toussaint, T. Lavergne, J. Ollitrault, E. Abergel, O. Paziaud, M. Ait Said, R. Sader, J.Y. Le Heuzey, L. Guize Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization Pacing Clin Electrophysiol 28 2005 1260 1270
16. M. Gasparini, M. Lunati, M. Santini, M. Tritto, A. Curnis, M. Bocchiardo, A. Vincenti, G. Pistis, S. Valsecchi, A. Denaro INSYNC/INSYNC ICD ITALIAN Registry Investigators Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian registry Pacing Clin Electrophysiol 29 suppl 2 2006 S2 S10
17. M.B. Kronborg, P.T. Mortensen, R.E. Kirkfeldt, J.C. Nielsen Very long term follow-up of cardiac resynchronization therapy: clinical outcome and predictors of mortality Eur J Heart Fail 10 2008 796 801
18. K. Guha, Z. Khalique, N. Pareek, B. Chandrasekaran, T.A. McDonagh, M.R. Cowie, R. Sharma The use of cardiac resynchronisation therapy may allow the optimisation of beta blocker therapy Eur J Heart Fail Suppl 10 suppl 1 2011 S20
19. R.J. van Bommel, C.J. Borleffs, C. Ypenburg, N.A. Marsan, V. Delgado, M. Bertini, E.E. van der Wall, M.J. Schalij, J.J. Bax Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome Eur Heart J 31 2010 2783 2790